![]() |
市場調査レポート
商品コード
1610755
医薬品ろ過の市場規模、シェア、成長分析、製品別、手法別、用途別、運用スケール別、エンドユーザー別、地域別 - 産業予測、2024年~2031年Pharmaceutical Filtration Market Size, Share, Growth Analysis, By Product, By Technique, By Application, By Scale of Operation, End User, By Region - Industry Forecast 2024-2031 |
||||||
|
医薬品ろ過の市場規模、シェア、成長分析、製品別、手法別、用途別、運用スケール別、エンドユーザー別、地域別 - 産業予測、2024年~2031年 |
出版日: 2024年12月08日
発行: SkyQuest
ページ情報: 英文 207 Pages
納期: 3~5営業日
|
医薬品ろ過の世界市場規模は、2022年に116億7,000万米ドルと評価され、2023年の126億1,000万米ドルから2031年には233億9,000万米ドルに成長し、予測期間中(2024年~2031年)のCAGRは8.0%で成長する見通しです。
医薬品ろ過の世界市場は、革新的な医薬品に対する需要の高まりと、医薬品の研究開発・製造プロセスを強化する厳しい規制の義務化によって、成長の態勢を整えています。新規創薬への投資強化により、ろ過製品およびソリューションの市場はさらに拡大すると予想されます。医薬品開発パイプラインの拡大と医薬品・生物製剤の商業化の高まりも、今後数年間の業界情勢に好影響を与えると思われます。さらに、新たな製造施設の設立や、先発医薬品とジェネリック医薬品の承認の急増も、ろ過需要を高めることになります。しかし、複雑なフィルタープロセスの検証、汚染リスク、厳格なコンプライアンス要件などの課題は、長期的には業界関係者に大きなハードルをもたらす可能性があります。
Global Pharmaceutical Filtration Market size was valued at USD 11.67 billion in 2022 and is poised to grow from USD 12.61 billion in 2023 to USD 23.39 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2024-2031).
The global market for pharmaceutical filtration is poised for growth, driven by an increasing demand for innovative drugs and stringent regulatory mandates that enhance pharmaceutical R&D and manufacturing processes. Enhanced investments in novel drug discovery are anticipated to further boost the market for filtration products and solutions. The expanding drug development pipelines and the rising commercialization of pharmaceuticals and biologics will also favorably impact the industry landscape over the coming years. Additionally, the establishment of new manufacturing facilities and a surge in approvals for branded and generic drugs are set to elevate filtration demand. However, challenges such as complex filter process validation, contamination risks, and stringent compliance requirements may present significant hurdles for industry players in the long term.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pharmaceutical Filtration market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Pharmaceutical Filtration Market Segmental Analysis
Global Pharmaceutical Filtration Market is segmented by product, technique, application, scale of operation, end user and region. Based on product, the market is segmented into membrane filters, cartridge filters, capsule filters, filter holders and filtration accessories. Based on technique, the market is segmented into microfiltration, ultrafiltration, nanofiltration and reverse osmosis. Based on application, the market is segmented into final product processing, raw material filtration, cell separation, water purification and air purification. Based on scale of operation, the market is segmented into manufacturing scale, pilot scale and research and development (R&D) scale. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Pharmaceutical Filtration Market
The global pharmaceutical filtration market is primarily driven by the expanding pharmaceutical manufacturing landscape. As the prevalence of chronic diseases rises, so too does the demand for effective drugs and biologics to address these health challenges. This surge in pharmaceutical production not only highlights the necessity for advanced filtration processes but also positions filtration as an essential component in ensuring product safety and quality. Consequently, with the ongoing increase in manufacturing activities in the pharmaceutical sector, the demand for filtration solutions is anticipated to grow significantly, reinforcing its pivotal role in the industry's operations.
Restraints in the Global Pharmaceutical Filtration Market
The complexity of filter process validation significantly restrains the Global Pharmaceutical Filtration market. Validating the filtration process in pharmaceuticals is a challenging and time-intensive endeavor due to the stringent regulations and standards that companies must adhere to. This intricate procedure necessitates comprehensive documentation, rigorous testing, and specialized knowledge to ensure the selected filtration method is appropriate for a specific drug. As a result, this complexity not only complicates the validation process but also hinders the widespread adoption of pharmaceutical filtration technologies, thereby impacting market growth and innovation in the industry.
Market Trends of the Global Pharmaceutical Filtration Market
The Global Pharmaceutical Filtration market is witnessing a significant trend towards the development of single-use filtration systems, heralded for their potential to mitigate contamination risks in production processes. This innovation not only enhances safety but also offers pharmaceutical manufacturers the advantages of rapid changeovers and reduced downtime, fostering greater agility and efficiency in manufacturing. As companies increasingly shift towards these flexible technologies, the demand for single-use filtration solutions is expected to surge, positioning it as a critical growth driver in the pharmaceutical filtration landscape. Over the long term, this trend will likely redefine operational standards and elevate competitive dynamics within the market.